Treatment efficacy of a titratable oral appliance in obstructive sleep apnea patients: a prospective clinical trial.
CONCLUSIONS: This clinical trial indicates that treatment with a novel custom-made OAm can reduce the severity of sleep-disordered breathing by significantly decreasing the AHI and VAS scores.
PMID: 27097387 [PubMed - in process]
Source: B-ENT - Category: ENT & OMF Tags: B-ENT Source Type: research
More News: Clinical Trials | ENT & OMF | Obstructive Sleep Apnea | Sleep Apnea | Sleep Disorders | Sleep Medicine | Snoring